---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-051141"
form_type: "8-K"
ticker: "REVB"
cik: "0001810560"
company_name: "REVELATION BIOSCIENCES, INC."
filed_at: "2023-10-02T23:59:59+00:00"
generated_at: "2026-06-10T06:28:58.820032+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Revelation Biosciences appoints Lakhmir Chawla to board; Curt LaBelle resigns

## Summary
- Curt LaBelle M.D. resigned from Board on Sept 27, 2023, not due to any disagreements.
- Lakhmir Chawla M.D. appointed as Class C director to fill vacancy, effective same date.
- Dr. Chawla is CEO of Stavro Medical; former CMO at Silver Creek Pharma and La Jolla Pharmaceutical.
- He will serve on Compensation and Nominations & Corporate Governance Committees.
- No transactions requiring Item 404(a) disclosure between Dr. Chawla and the company.

## SEC filing metadata
- accession: 0000950170-23-051141
- form_type: 8-K
- ticker: REVB
- cik: 0001810560
- company_name: REVELATION BIOSCIENCES, INC.
- filed_at: 2023-10-02T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1810560/000095017023051141/0000950170-23-051141-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1810560/000095017023051141/revb-20230927.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-051141
- JSON: https://secwatch.observer/filing/0000950170-23-051141.json
- Plain text: https://secwatch.observer/filing/0000950170-23-051141.txt

## Key facts
- Executive change
  Lakhmir Chawla was elected as Director at REVELATION BIOSCIENCES, INC..
  - Action: elected
  - Role: Director
  source text: On September 27, 2023, the Board of Directors elected Lakhmir Chawla M.D. (age 53) to the Board of Directors, as a Class C Director to fill the vacancy created by the resignation of Dr. La Belle.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1810560/000095017023051141/0000950170-23-051141-index.htm
- Executive change
  Curt LaBelle resigned as Director at REVELATION BIOSCIENCES, INC..
  - Action: resigned
  - Role: Director
  source text: On September 27, 2023, Curt LaBelle, M.D., resigned from the Board of Directors of Revelation Biosciences, Inc. (the "Company").
  evidence_url: https://www.sec.gov/Archives/edgar/data/1810560/000095017023051141/0000950170-23-051141-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.